vs
百富门（BF.B）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
百富门的季度营收约是Royalty Pharma plc的1.7倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 21.6%，领先12.8%），Royalty Pharma plc同比增速更快（4.8% vs -5.4%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -1.6%）
百富门（Brown-Forman）是美国家族控股上市企业，属全球规模最大的葡萄酒及烈酒经营集团之一，总部位于肯塔基州路易斯维尔。旗下拥有杰克丹尼、伍德福德珍藏、格兰多纳等多个国际知名酒类品牌，曾持有的南方安逸等品牌已于2016年出售。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BF.B vs RPRX — 直观对比
营收规模更大
BF.B
是对方的1.7倍
$622.0M
营收增速更快
RPRX
高出10.2%
-5.4%
净利率更高
RPRX
高出12.8%
21.6%
两年增速更快
RPRX
近两年复合增速
-1.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $622.0M |
| 净利润 | $224.0M | $214.2M |
| 毛利率 | 59.4% | — |
| 营业利润率 | 29.4% | 62.4% |
| 净利率 | 21.6% | 34.4% |
| 营收同比 | -5.4% | 4.8% |
| 净利润同比 | -13.2% | 2.9% |
| 每股收益（稀释后） | $0.47 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BF.BRPRX
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $924.0M | $609.3M | ||
| Q2 25 | $894.0M | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $951.0M | $564.7M | ||
| Q2 24 | $964.0M | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润BF.BRPRX
| Q4 25 | $224.0M | $214.2M | ||
| Q3 25 | $170.0M | $288.2M | ||
| Q2 25 | $146.0M | $30.2M | ||
| Q1 25 | $270.0M | $238.3M | ||
| Q4 24 | $258.0M | $208.2M | ||
| Q3 24 | $195.0M | $544.0M | ||
| Q2 24 | $266.0M | $102.0M | ||
| Q1 24 | $285.0M | $4.8M |
毛利率BF.BRPRX
| Q4 25 | 59.4% | — | ||
| Q3 25 | 59.7% | — | ||
| Q2 25 | 57.4% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | 59.0% | — | ||
| Q3 24 | 59.4% | — | ||
| Q2 24 | 59.0% | — | ||
| Q1 24 | 59.4% | — |
营业利润率BF.BRPRX
| Q4 25 | 29.4% | 62.4% | ||
| Q3 25 | 28.1% | 70.1% | ||
| Q2 25 | 22.9% | 36.3% | ||
| Q1 25 | 27.1% | 94.0% | ||
| Q4 24 | 31.1% | 60.9% | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 38.9% | 50.2% | ||
| Q1 24 | 34.9% | -13.0% |
净利率BF.BRPRX
| Q4 25 | 21.6% | 34.4% | ||
| Q3 25 | 18.4% | 47.3% | ||
| Q2 25 | 16.3% | 5.2% | ||
| Q1 25 | 26.1% | 41.9% | ||
| Q4 24 | 23.6% | 35.1% | ||
| Q3 24 | 20.5% | 96.3% | ||
| Q2 24 | 27.6% | 19.0% | ||
| Q1 24 | 26.7% | 0.8% |
每股收益（稀释后）BF.BRPRX
| Q4 25 | $0.47 | $0.49 | ||
| Q3 25 | $0.36 | $0.67 | ||
| Q2 25 | $0.31 | $0.07 | ||
| Q1 25 | $0.57 | $0.55 | ||
| Q4 24 | $0.55 | $0.46 | ||
| Q3 24 | $0.41 | $1.21 | ||
| Q2 24 | $0.56 | $0.23 | ||
| Q1 24 | $0.60 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $319.0M | $618.7M |
| 总债务越低越好 | $2.4B | $9.0B |
| 股东权益账面价值 | $4.1B | $9.7B |
| 总资产 | $8.2B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.59× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BF.BRPRX
| Q4 25 | $319.0M | $618.7M | ||
| Q3 25 | $471.0M | $938.9M | ||
| Q2 25 | $444.0M | $631.9M | ||
| Q1 25 | $599.0M | $1.1B | ||
| Q4 24 | $416.0M | $929.0M | ||
| Q3 24 | $416.0M | $950.1M | ||
| Q2 24 | $446.0M | $1.8B | ||
| Q1 24 | $589.0M | $843.0M |
总债务BF.BRPRX
| Q4 25 | $2.4B | $9.0B | ||
| Q3 25 | $2.4B | $8.9B | ||
| Q2 25 | $2.4B | $8.0B | ||
| Q1 25 | $2.7B | $7.6B | ||
| Q4 24 | $2.7B | $7.6B | ||
| Q3 24 | $2.7B | $7.6B | ||
| Q2 24 | $2.7B | $7.6B | ||
| Q1 24 | $2.7B | $6.1B |
股东权益BF.BRPRX
| Q4 25 | $4.1B | $9.7B | ||
| Q3 25 | $4.0B | $9.6B | ||
| Q2 25 | $4.0B | $9.5B | ||
| Q1 25 | $3.8B | $9.8B | ||
| Q4 24 | $3.7B | $10.3B | ||
| Q3 24 | $3.5B | $10.3B | ||
| Q2 24 | $3.5B | $9.8B | ||
| Q1 24 | $3.2B | $9.9B |
总资产BF.BRPRX
| Q4 25 | $8.2B | $19.6B | ||
| Q3 25 | $8.2B | $19.3B | ||
| Q2 25 | $8.1B | $18.3B | ||
| Q1 25 | $8.1B | $17.6B | ||
| Q4 24 | $8.3B | $18.2B | ||
| Q3 24 | $8.2B | $18.0B | ||
| Q2 24 | $8.2B | $17.7B | ||
| Q1 24 | $8.2B | $16.1B |
负债/权益比BF.BRPRX
| Q4 25 | 0.59× | 0.92× | ||
| Q3 25 | 0.61× | 0.93× | ||
| Q2 25 | 0.61× | 0.84× | ||
| Q1 25 | 0.70× | 0.78× | ||
| Q4 24 | 0.73× | 0.74× | ||
| Q3 24 | 0.77× | 0.74× | ||
| Q2 24 | 0.76× | 0.78× | ||
| Q1 24 | 0.83× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $132.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $107.0M | — |
| 自由现金流率自由现金流/营收 | 10.3% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | 0.59× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $610.0M | — |
8季度趋势，按日历期对齐
经营现金流BF.BRPRX
| Q4 25 | $132.0M | $827.1M | ||
| Q3 25 | $160.0M | $702.6M | ||
| Q2 25 | $152.0M | $364.0M | ||
| Q1 25 | $317.0M | $596.1M | ||
| Q4 24 | $112.0M | $742.5M | ||
| Q3 24 | $17.0M | $703.6M | ||
| Q2 24 | $285.0M | $658.2M | ||
| Q1 24 | $265.0M | $664.6M |
自由现金流BF.BRPRX
| Q4 25 | $107.0M | — | ||
| Q3 25 | $129.0M | — | ||
| Q2 25 | $102.0M | — | ||
| Q1 25 | $272.0M | — | ||
| Q4 24 | $81.0M | — | ||
| Q3 24 | $-24.0M | — | ||
| Q2 24 | $205.0M | — | ||
| Q1 24 | $196.0M | — |
自由现金流率BF.BRPRX
| Q4 25 | 10.3% | — | ||
| Q3 25 | 14.0% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | -2.5% | — | ||
| Q2 24 | 21.3% | — | ||
| Q1 24 | 18.3% | — |
资本支出强度BF.BRPRX
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 6.5% | — |
现金转化率BF.BRPRX
| Q4 25 | 0.59× | 3.86× | ||
| Q3 25 | 0.94× | 2.44× | ||
| Q2 25 | 1.04× | 12.06× | ||
| Q1 25 | 1.17× | 2.50× | ||
| Q4 24 | 0.43× | 3.57× | ||
| Q3 24 | 0.09× | 1.29× | ||
| Q2 24 | 1.07× | 6.45× | ||
| Q1 24 | 0.93× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BF.B
| Whiskey | $771.0M | 74% |
| Ready To Drink | $138.0M | 13% |
| Tequila | $67.0M | 6% |
| Restofportfolio | $52.0M | 5% |
| Nonbrandedandbulk | $8.0M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
